GH Research PLC GHRS
23.84
(0.61)
(2.49%)
as of 25 Sep
- Market cap
- $1.7B
- P/E
- 0.0×
Follow GHRS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
34.13 | 17.23 | 24.49 | 37.07 | 101.80 | 24.03 | 4.85 | — |
Net Debt/EBITDA |
4.65 | 2.98 | 3.93 | 5.44 | 18.35 | 13.22 | 1.61 | — |
Debt/Assets |
0.05% | 0.20% | 0.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.90 | 1.09 | 0.94 | 1.17 | 1.66 | 0.74 | 0.93 | — |
Capex/Depreciation |
(0.36) | (0.16) | (0.32) | (1.43) | (5.47) | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (21.04%) | (19.58%) | (15.18%) | (8.52%) | (6.51%) | (14.70%) | (10.34%) | — | |
| (20.26%) | (18.80%) | (14.81%) | (8.41%) | (6.44%) | (13.90%) | (123.02%) | — | |
ROIC |
0.00% | (104.83%) | (44.39%) | (22.77%) | (2,365.29%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(17.35%) | (26.68%) | (22.46%) | (13.69%) | (3.32%) | (7.87%) | (77.50%) | — |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Free Cash Flow per Share |
(0.72) | (0.81) | (0.64) | (0.50) | (0.35) | (0.01) | 0.00 | — |
Cash per Share |
4.60 | 2.87 | 3.11 | 3.19 | 6.34 | 0.21 | 0.01 | — |
Shareholders Equity per Share |
4.58 | 3.44 | 4.21 | 4.80 | 6.35 | 0.20 | 0.01 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
4.58 | 3.44 | 4.21 | 4.80 | 6.35 | 0.20 | 0.01 | — |
Free Cash Flow |
(43.67) | (42.33) | (33.44) | (26.27) | (15.39) | (0.33) | (0.29) | — |
Working Capital |
277.60 | 145.27 | 157.39 | 164.00 | 277.09 | 5.67 | 0.40 | — |
Capital Expenditures |
(0.12) | (0.05) | (0.10) | (0.07) | (0.10) | — | — | — |
Net Current Asset Value |
277.45 | 144.90 | 156.76 | 164.00 | 277.09 | 5.67 | 0.40 | — |
| Other line items | ||||||||
Quick Ratio |
33.50 | 16.68 | 24.11 | 36.51 | 100.68 | 23.96 | 4.79 | — |
Depreciation/Fixed assets |
0.54 | 0.42 | 0.29 | 0.48 | 0.23 | — | — | — |
Cash ROIC |
(7.88%) | (13.09%) | (9.03%) | (6.32%) | (2.77%) | (2.85%) | (32.18%) | — |
Accounts Receivable Turnover |
— | — | — | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.71) | (0.81) | (0.64) | (0.50) | (0.35) | (0.01) | 0.00 | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
— | — | — | 0.07 | — | — | — | — |
Average Payables |
3.76 | 3.62 | 2.68 | 1.38 | 0.44 | 0.05 | 0.05 | — |
Average Assets |
238.25 | 207.29 | 240.33 | 267.14 | 142.92 | 3.21 | 0.25 | — |
Average Common Equity |
229.33 | 198.96 | 234.39 | 263.50 | 141.42 | 3.03 | 3.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates